Elucidation of the VIP pharmacophore for human VPAC1 and VPAC2 and development of simplified VIP analogs with receptor selectivity and stability

被引：0
|
作者：
Igarashi, Hisato
Ito, Tetsuhide
Yoshinaga, Masahiro
Sakai, Hironori
Muto, Yoichi
Takayanagi, Ryoichi
Coy, David H.
Jensen, Robert T.
机构：
[1] Beppu Med Ctr, Div Gastroenterol, Beppu, Oita, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan
[3] Tulane Univ, Ctr Hlth Sci, Peptide Res Labs, Dept Med, New Orleans, LA 70118 USA
[4] NIDDK, NIH, Digest Dis Branch, Bethesda, MD USA
来源：
REGULATORY PEPTIDES | 2006年 / 135卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [1] In Silico Classification and Prediction of VIP Derivatives as VPAC1/VPAC2 Receptor Agonists/Antagonists
    Li, Jiazhong
    Wang, Xin
    Liu, Huanxiang
    Li, Hongyu
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2015, 18 (01) : 33 - 41
  • [2] Development of simplified multi-alaninated VIP analogues with receptor subtype selectivity and stability for human VPAC1
    Igarashi, H
    Ito, T
    Pradhan, TK
    Hou, W
    Mantey, SA
    Coy, DH
    Jensen, RT
    GASTROENTEROLOGY, 2002, 122 (04) : A377 - A377
  • [3] Alanine-scanning of VIP and molecular modeling of VIP analogs: Determination of important residues for interaction with human VPAC1 and VPAC2 receptors
    Laburthe, M
    Nicole, P
    Rouyer-Fessard, C
    Couvineau, A
    Maoret, JJ
    Drouot, C
    Fulcrand, P
    Martinez, J
    Lins, L
    Thomas, A
    Brasseur, R
    GASTROENTEROLOGY, 1999, 116 (04) : A621 - A621
  • [4] Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC2 receptors in human and rat and comparison to the pharmacophore for VPAC1 receptors
    Igarashi, H
    Ito, T
    Pradhan, TK
    Mantey, SA
    Hou, W
    Coy, DH
    Jensen, RT
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (02): : 445 - 460
  • [5] THE EXPRESSION OF VIP RECEPTORS, VPAC1 AND VPAC2, IS RELATED TO DISEASE ACTIVITY IN PATIENTS WITH EARLY ARTHRITIS
    Ortiz, A. M.
    Piris, L.
    Gonzalez-Alvaro, I.
    Seoane, I. V.
    Lamana, A.
    Juarranz, Y.
    Leceta, J.
    Gomariz, R. P.
    Martinez, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 839 - 839
  • [6] Internalization and trafficking of the VIP receptors:: A comparison between the recombinant VPAC1 and VPAC2 human receptors expressed in cho cells
    Langlet, C
    Gaspard, N
    Vertongen, P
    Robberecht, P
    Langer, I
    REGULATORY PEPTIDES, 2004, 122 (01) : 26 - 26
  • [7] Tryptophan 67 in the human VPAC1 receptor:: Crucial role for VIP binding
    Nicole, P
    Maoret, JJ
    Couvineau, A
    Momany, FA
    Laburthe, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 276 (02) : 654 - 659
  • [8] Role of VPAC1 and VPAC2 in VIP mediated inhibition of rat pulmonary artery and aortic smooth muscle cell proliferation
    St Hilaire, Rose-Claire
    Murthy, Subramanyam N.
    Kadowitz, Philip J.
    Jeter, James R., Jr.
    PEPTIDES, 2010, 31 (08) : 1517 - 1522
  • [9] VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors
    Cunha-Reis, D
    Ribeiro, JA
    Sebastiao, AM
    REGULATORY PEPTIDES, 2005, 130 (03) : 159 - 160
  • [10] Location and function of VPAC1, VPAC2 and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries
    Grant, S
    Lutz, EM
    McPhaden, AR
    Wadsworth, RM
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2006, 26 (01): : 58 - 67
12345